Schulze-Koops H, Krueger K, Vallbracht I, Hasseli R, et al. Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab. Ann Rheum Dis 2021;80:e67.
PMID: 32591357